2LRA

NMR Structure of Signal Sequence Deleted (SSD) Rv0603 Protein from Mycobacterium tuberculosis without N-terminal His-tag

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	20 mM sodium phosphate-1, 50 mM sodium chloride-2, 0.1 % sodium azide-3, 1 mM AEBSF protease inhibitor-4, 1 mM [U-99% 15N] Rv0603-SSD-5	93% H2O/7% D2O	50	6.5	ambient	298
2	3D HNCACB	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
3	3D CBCA(CO)NH	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
4	3D HNCO	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
5	3D HN(CO)CA	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
6	3D H(CCO)NH	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
7	3D C(CO)NH	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
8	3D HCCH-TOCSY	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
9	2D 1H-13C HSQC aliphatic	20 mM sodium phosphate-11, 50 mM sodium chloride-12, 0.1 % sodium azide-13, 1 mM AEBSF protease inhibitor-14, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-15	100% D2O	50	6.5	ambient	298
10	2D 1H-13C HSQC aromatic	20 mM sodium phosphate-11, 50 mM sodium chloride-12, 0.1 % sodium azide-13, 1 mM AEBSF protease inhibitor-14, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-15	100% D2O	50	6.5	ambient	298
11	2D CB(CGCD)HD	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
12	2D CB(CGCE)HE	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
13	2D 1H-1H NOESY aromatic	20 mM sodium phosphate-6, 50 mM sodium chloride-7, 0.1 % sodium azide-8, 1 mM AEBSF protease inhibitor-9, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-10	93% H2O/7% D2O	50	6.5	ambient	298
14	3D 1H-15N NOESY	20 mM sodium phosphate-1, 50 mM sodium chloride-2, 0.1 % sodium azide-3, 1 mM AEBSF protease inhibitor-4, 1 mM [U-99% 15N] Rv0603-SSD-5	93% H2O/7% D2O	50	6.5	ambient	298
15	3D 1H-13C NOESY aliphatic	20 mM sodium phosphate-11, 50 mM sodium chloride-12, 0.1 % sodium azide-13, 1 mM AEBSF protease inhibitor-14, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-15	100% D2O	50	6.5	ambient	298
16	3D 1H-13C NOESY aromatic	20 mM sodium phosphate-11, 50 mM sodium chloride-12, 0.1 % sodium azide-13, 1 mM AEBSF protease inhibitor-14, 1 mM [U-99% 13C; U-99% 15N] Rv0603-SSD-15	100% D2O	50	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600

NMR Refinement
Method	Details	Software
water refinement		Cyana3.0

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	Cyana3.0		Guntert, Mumenthaler and Wuthrich
2	validation of structure quality	PSVS	1.4	Bhattacharya and Montelione
3	refinement	CNS	solve_1.21